Although published in 2017, these papers are still viewed as the current standard of care. They are reviewed regularly and are up for review this December 4 – 5, 2022 at the International IBC Conference hosted in Houston, TX at MD Anderson.

The links to the papers, all open-access are below for your reading.

First paper:

Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G, DeSnyder SM, Teshome M, Chang E, Lim B, Krishnamurthy S, Stauder MC, Parmar S, Mohamed MM, Alexander A, Valero V, Woodward WA. International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. J Cancer 2018; 9(8):1437-1447. doi:10.7150/jca.23969. Available from http://www.jcancer.org/v09p1437.htm

(**We especially wish to highlight this paper because its builds on the previously published version of the guidelines published in 2011)

Second paper:

Woodward WA, Cristofanilli M, Merajver SD, Van Laere S, Pusztai L, Bertucci F, Berditchevski F, Polyak K, Overmoyer B, Devi GR, Sterneck E, Schneider R, Debeb BG, Wang X, van Golen KL, El-Zein R, Rahal OM, Alexander A, Reuben JM, Krishnamurthy S, Lucci A, Ueno NT. Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference. J Cancer 2017; 8(17):3607-3614. doi:10.7150/jca.21200. Available from http://www.jcancer.org/v08p3607.htm

This paper is more of a scientific summary of ongoing research in IBC and where we will be going in the coming few years.

Third paper:

Alexander A, Arnold TL, Bishnoi S, Ballinger C, Shaitelman SF, Schaverien MV, Cohen L, Dev M, Ueno NT. Survivorship and Advocacy in Inflammatory Breast Cancer. J Cancer 2018; 9(8):1430-1436. doi:10.7150/jca.21281. Available from http://www.jcancer.org/v09p1430.htm

This is the first manuscript describing anything related to IBC advocacy and survivorship. Given the improvements in outcomes with better systemic and locoregional treatments, we feel it is time to more carefully consider these unique needs in our routine care of IBC patients.

Inflammatory Breast Cancer Treatment Algorithm

Translate »

Pin It on Pinterest

Share This